Peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia and tyrosine kinase inhibitor response: Questions remain! Ozdemir ZN, Eskazan AE. Cancer 2025;131:e70215.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ozdemir ZN, Eskazan AE. Peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia and tyrosine kinase inhibitor response: Questions remain! Cancer 2025;131:e70215.
PMID: 41370184